Table 2.
CD | UC | C | Control group | Biopsies | H. pylori (+) gastritis (%) | H. pylori (-) gastritis (%) | Ref. |
37 | 43 | 41 | Non-IBD patients | Antrum, body | CD: 27, UC: 37.2 C: 53.7 | CD: 29.6, UC: 22.2 C: 10.5 | [61] |
141 | 79 | 141 | Non-IBD patients | Antrum, angulus, body | CD: 33, UC: 47 C: 60 | CD: 43, UC: 12 C: 19 | [34] |
75 | 0 | 200 | CD-free patients | Antrum, body | CD: 33.3, UC: NA C: 48 | CD: 39, UC: NA C: 0.8 | [50] |
208 | 280 | 4943 | Non-IBD patients | Antrum, body | CD: 4, UC: 6 C: 7 | CD: 5, UC: 0 C: 0 | [63] |
67 | 41 | 43 | Healthy subjects | Antrum, body | CD: 17.6, UC: 6.4 C: 20 | CD: 45.4 , UC: 15.6 C: 30 | [33] |
62 | 0 | 0 | NA | Antrum, corpus | CD: 9.7, UC: NA C: NA | CD: 32 , UC: NA C: NA | [64] |
CD: Crohn’s disease; UC: Ulcerative colitis; C: Controls; IBD: Inflammatory bowel disease; H. pylori: Helicobacter pylori; NA: Not applicable.